Urological cancer, Malmö
1 – 10 of 559
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Peritoneal recurrence following nephrectomy for localized renal cancer : A multicenter European real-world analysis of incidence, pattern and treatment (PEMET study–UroCCR 124)
- Contribution to journal › Article
- 2025
-
Mark
Validation of a Swedish version of the National Institute of Health - Chronic Prostatitis Symptom Index
- Contribution to journal › Article
-
Mark
Reply to Francesco Montorsi, Giorgio Gandaglia, Francesco Barletta, and Alberto Briganti's Letter to the Editor re : Andreas Josefsson, Marianne Månsson, Kimia Kohestani, et al. Performance of 4Kscore as a Reflex Test to Prostate-specific Antigen in the GÖTEBORG-2 Prostate Cancer Screening Trial. Eur Urol 2024;86:223-9
- Contribution to journal › Article
-
Mark
Adverse prognosis gene expression patterns in metastatic castration-resistant prostate cancer
- Contribution to journal › Article
-
Mark
An optimised Bcl-3 inhibitor for melanoma treatment
- Contribution to journal › Article
-
Mark
pSTAT3 Expression is Increased in Advanced Prostate Cancer in Post-Initiation of Androgen Deprivation Therapy
- Contribution to journal › Article
-
Mark
Clinical validation of a biopsy-based six-gene signature prognostic for aggressive prostate cancer
- Contribution to journal › Article
-
Mark
Evaluating Biparametric Versus Multiparametric Magnetic Resonance Imaging for Diagnosing Clinically Significant Prostate Cancer : An International, Paired, Noninferiority, Confirmatory Observer Study
- Contribution to journal › Article
-
Mark
What's in a Name? Why Words Matter in Advanced Prostate Cancer
- Contribution to journal › Debate/Note/Editorial
-
Mark
Randomized trials of PSA screening
- Contribution to journal › Scientific review
